首页> 外文OA文献 >Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines

【2h】

Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines

机译：淋巴细胞白血病对白消安的敏感性要比对髓样白血病的易感性高吗？丁硫丹，美法仑，氟达拉滨，氯法拉滨，胞嘧啶阿拉伯糖苷和依托泊苷对人骨髓和淋巴白血病细胞系的细胞毒性比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kamishohara Masaru; Komatsubara Hirofumi; Kakinuma Hayato; Tanaka Ryo; Nakamura Yuki; Kobayashi Hiroyuki;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines [J] . Kamishohara Masaru, Komatsubara Hirofumi, Kakinuma Hayato, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：淋巴细胞白血病比髓样白血病对白消安的敏感性低吗？白消安，美法仑，氟达拉滨，氯法拉滨，胞嘧啶阿拉伯糖苷和依托泊苷对人髓样和淋巴白血病细胞系的细胞毒性比较
2. Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid Leukemia [J] . El-Jawahri Areej, Li Shuli, Ballen Karen K., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第1期

机译：急性髓性白血病，骨髓增生异常综合征和急性淋巴性白血病患者异体造血干细胞移植降低强度的丁硫丹/氯法拉滨调理的第二阶段试验
3. Reduced Intensity Conditioning (RIC) Regimens Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML): A Comparison of Fludarabine/Busulfan (FB) and Fludarabine/Melphalan (FM) Based Regimens from the CIBMTR [J] . Nath Rajneesh, Zhou Zheng, Cerny Jan, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：减少强度调理（RIC）方案造血细胞移植（HCT）用于急性髓性白血病（AML）：从CibMTR中的氟氮滨/伯氟烷（FB）和氟氨拉滨/脲醛（FM）的方案进行比较
4. FT-infrared spectroscopic studies of lymphoma, lymphoid, and myeloid leukemia cell lines [C] . Jaspreet Babrah, Keith P. McCarthy, Richard Lush, Conference on Diagnostic Optical Spectroscopy in Biomedicine . 2007

机译：淋巴瘤，淋巴和髓性白血病细胞系FT红外光谱研究
5. Culture, characterization, and cytotoxic activity of gammadelta T cells from patients with Ph(+) chronic myeloid leukemia: A potential role in cell therapy. [D] . Malas Al-Beirouti, Bassim Tahseen. 2002

机译：来自Ph（+）慢性髓细胞性白血病患者的γδT细胞的培养，鉴定和细胞毒性活性：在细胞治疗中的潜在作用。
6. Synergistic cytotoxicity of sorafenib with busulfan and nucleoside analogs in human FLT3-ITD-positive acute myeloid leukemia cells [O] . Guiyun Song, Benigno C. Valdez, Yang Li, -1

机译：索拉非尼与白消安和核苷类似物在人FLT3-ITD阳性急性髓细胞白血病细胞中的协同细胞毒性
7. Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid Leukemia [O] . El-Jawahri Areej, Li Shuli, Ballen Karen K., 2016

机译：急性髓性白血病，骨髓增生异常综合征和急性淋巴性白血病患者异体造血干细胞移植降低强度的丁硫丹/氯法拉滨调理的第二阶段试验
8. Incidence of Lymphoid and Myeloid Leukemia in US Active-Duty Military Men According to Occupation and Comparisons with Incidence from the US surveillance Epidemiology and End Results (SEER) Populations [R] . Gorham, E. D. , Groves, F. , Garland, C. F. , 2002

机译：根据职业情况和美国监测流行病学和最终结果（sEER）人群的发病率比较美国现役军人中淋巴和髓细胞白血病的发病率

Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines

著录项

引文网络

相似文献

相关主题

期刊订阅